待处理
入排:排除
图源:待检查
Correction: Efficacy and safety of fremanezumab in clinical trial participants aged ≥60 years with episodic or chronic migraine: pooled results from 3 randomized, double-blind, placebo-controlled phase 3 studies.
Stephanie J Nahas, Steffen Naegel, Joshua M Cohen, Xiaoping Ning, Lindsay Janka, Verena Ramirez Campos, Lynda J Krasenbaum, Dagny Holle-Lee, David Kudrow, Christian Lampl
J Headache Pain 23(1) 57
摘要
摘要
无摘要
KM 提取结果
0 个 Figure · 0 个 KM 面板